- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Kathleen Blake Outlines How Burnout Affects Specialties Differently
Looking at how burnout affects specialties differently shows that it’s not a work–life balance issues, but a systems one, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.
Looking at how burnout affects specialties differently shows that it’s not a work—life balance issues, but a systems one, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.
Transcript
Does the American Medical Association have information about how burnout affects different specialties?
Yes, and our 2 surveys published, so far, and the one that’s currently being analyzed, do break it down by physicians’ specialties. And we do look at the internal medicine subspecialties, which includes, of course, oncology. Where I find that data particularly interesting is that the field with the highest rate of burnout is emergency medicine, but the field with the highest favorable rating on work­—life balance is emergency medicine. So what that says to you, that paradox or seeming paradox, to me is really strong evidence: it’s not a work–life balance, it’s not a commitment problem, but that really have to focus on the systems problems.
Final words on the issue of burnout?
I think this is a treatable issue, a solvable problem. But I think if I leave the viewers with nothing else, I would want to say: it’s worth solving. It’s good for all of us. It’s good for clinicians, it’s good for health systems. But, most of all, it’s better for patients. And, quite frankly, we will all be patients at some point in our lives. I would really hope that we could have addressed this in a way so that we all have the kind of health and healthcare that we really want.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
